Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues.

Published on Aug 25, 2016in Stem Cell Research & Therapy5.116
· DOI :10.1186/S13287-016-0383-3
Raffaella Fazzina8
Estimated H-index: 8
Paola Iudicone10
Estimated H-index: 10
+ 4 AuthorsLuca Pierelli34
Estimated H-index: 34
(Sapienza University of Rome)
Background Mesenchymal stromal cells (MSCs) have been largely investigated, in the past decade, as potential therapeutic strategies for various acute and chronic pathological conditions. MSCs isolated from different sources, such as bone marrow (BM), umbilical cord tissue (UCT) and adipose tissue (AT), share many biological features, although they may show some differences on cumulative yield, proliferative ability and differentiation potential. The standardization of MSCs growth and their functional amplification is a mandatory objective of cell therapies. The aim of this study was to evaluate the cumulative yield and the ex vivo amplification potential of MSCs obtained from various sources and different subjects, using defined culture conditions with a standardized platelet lysate (PL) as growth stimulus.
📖 Papers frequently viewed together
196 Citations
31 Citations
18 Citations
#1Raffaella FazzinaH-Index: 8
#2Paola IudiconeH-Index: 10
Last. Luca PierelliH-Index: 34
view all 9 authors...
Alternatives to the use of fetal bovine serum (FBS) have been investigated to ensure xeno-free growth condition. In this study we evaluated the efficacy of human platelet lysate (PL) as a substitute of FBS for the in vitro culture of some human cell lines. PL was obtained by pools of pathogen inactivated human donor platelet (PLT) concentrates. Human leukemia cell lines (KG-1, K562, JURKAT, HL-60) and epithelial tumor cell lines (HeLa and MCF-7) were cultured with either FBS or PL. Changes in ce...
17 CitationsSource
#1Tiziana Squillaro (Seconda Università degli Studi di Napoli)H-Index: 14
#1Tiziana Squillaro (Seconda Università degli Studi di Napoli)H-Index: 3
Last. Umberto Galderisi (TU: Temple University)H-Index: 37
view all 3 authors...
In the last year, the promising features of mesenchymal stem cells (MSCs), including their regenerative properties and ability to differentiate into diverse cell lineages, have generated great interest among researchers whose work has offered intriguing perspectives on cell-based therapies for various diseases. Currently the most commonly used adult stem cells in regenerative medicine, MSCs, can be isolated from several tissues, exhibit a strong capacity for replication in vitro, and can differe...
631 CitationsSource
#1Qiushi Wang (PRC: China Medical University (PRC))H-Index: 5
#2Qiaoni Yang (PRC: China Medical University (PRC))H-Index: 1
Last. Zhengwei Yuan (PRC: China Medical University (PRC))H-Index: 13
view all 9 authors...
To characterize different tissue MSCs as sources of cell immunomodulatory therapy. Examined the effects of IFN-γ on WJ-MSC and their immunomodulatory function characteristics. We compared human fetal bone marrow (F-BM), adipose tissue (AT), and Warton's Jelly-derived MSCs (WJ-MSCs) for surface antigen expression, differentiation ability, proliferation capacity, clonality, tolerance for aging, gene expression, and whether IFN-γ affected WJ-MSC gene expression, as determined by real time quantitat...
61 CitationsSource
#1Vijay Bhaskar Reddy Konala (AMET University)H-Index: 3
#2Murali Krishna Mamidi (Manipal University)H-Index: 14
Last. Rajarshi Pal (Manipal University)H-Index: 20
view all 6 authors...
The unique properties of mesenchymal stromal/stem cells (MSCs) to self-renew and their multipotentiality have rendered them attractive to researchers and clinicians. In addition to the differentiation potential, the broad repertoire of secreted trophic factors (cytokines) exhibiting diverse functions such as immunomodulation, anti-inflammatory activity, angiogenesis and anti-apoptotic, commonly referred to as the MSC secretome, has gained immense attention in the past few years. There is enough ...
203 CitationsSource
#1Camilla Siciliano (IIT: Istituto Italiano di Tecnologia)H-Index: 10
#2Isotta ChimentiH-Index: 22
Last. Elena De FalcoH-Index: 19
view all 11 authors...
Human adipose tissue-derived mesenchymal stem cells (ADMSCs) are considered eligible candidates for cardiovascular stem cell therapy applications due to their cardiac transdifferentiation potential and immunotolerance. Over the years, the in vitro culture of ADMSCs by platelet lysate (PL), a hemoderivate containing numerous growth factors and cytokines derived from platelet pools, has allowed achieving a safe and reproducible methodology to obtain high cell yield prior to clinical administration...
10 CitationsSource
#1R. SecundaH-Index: 1
#2Rosy VennilaH-Index: 1
Last. R. SurendranH-Index: 2
view all 6 authors...
The multipotent and immunosuppressive capacities of mesenchymal stem cells (MSCs) attract several scientists worldwide towards translational research focusing on treatment of diseases including liver failure. Though MSC’s have been isolated from different sources, researchers do not concur on the best source for expansion and clinical translation. In this study, we have compared the isolation, proliferation and expansion of MSCs from umbilical cord blood (UCB), Wharton’s Jelly (WJ), bone marrow ...
101 CitationsSource
#1Raffaella FazzinaH-Index: 8
#2Andrea Mariotti (CUA: The Catholic University of America)H-Index: 14
Last. Giuseppina Bonanno (CUA: The Catholic University of America)H-Index: 33
view all 8 authors...
BACKGROUND Mesenchymal stromal cells (MSCs) isolated from human umbilical cord tissue (UCT) can be considered the perfect candidates for cell-based therapies and regenerative medicine. UCT-derived MSCs can be cryogenically stored in cell banks and expanded as needed for therapeutic uses. STUDY DESIGN AND METHODS We developed a new method for UCT-MSC isolation, cryopreservation, and expansion, following all criteria required by a stem cell bank. UCT-MSCs were isolated either by manual dissociatio...
8 CitationsSource
#1Rita N. BárciaH-Index: 13
#2Jorge M. SantosH-Index: 15
Last. P. CruzH-Index: 3
view all 19 authors...
MSCs derived from the umbilical cord tissue, termed UCX, were investigated for their immunomodulatory properties and compared to bone marrow-derived MSCs (BM-MSCs), the gold-standard in immunotherapy. Immunogenicity and immunosuppression were assessed by mixed lymphocyte reactions, suppression of lymphocyte proliferation and induction of regulatory T cells. Results showed that UCX were less immunogenic and showed higher immunosuppression activity than BM-MSCs. Further, UCX did not need prior act...
48 CitationsSource
#1Chun-yu Li (CDUTCM: Chengdu University of Traditional Chinese Medicine)H-Index: 1
#2Xiao-yun WuH-Index: 1
Last. Zhi-jie Ma (Capital Medical University)H-Index: 1
view all 8 authors...
Introduction Mesenchymal stem cells (MSCs) are promising candidates for cell-based therapies. Human platelet lysate represents an efficient alternative to fetal bovine serum for clinical-scale expansion of MSCs. Different media used in culture processes should maintain the biological characteristics of MSCs during multiple passages. However, bone marrow-derived MSCs and adipose tissue-derived MSCs have not yet been directly compared with each other under human platelet lysate conditions. This st...
196 CitationsSource
#1Camilla Siciliano (IIT: Istituto Italiano di Tecnologia)H-Index: 10
#2Mohsen Ibrahim (WashU: Washington University in St. Louis)H-Index: 19
Last. Elena De Falco (Sapienza University of Rome)H-Index: 19
view all 8 authors...
Mesenchymal stem cells (MSCs) are adult multipotent cells currently employed in several clinical trials due to their immunomodulating, angiogenic and repairing features. The adipose tissue is certainly considered an eligible source of MSCs. Recently, putative adipose tissue derived MSCs (ADMSCs) have been isolated from the mediastinal depots. However, very little is known about the properties, the function and the potential of human mediastinal ADMSCs (hmADMSCs). However, the lack of standardize...
24 CitationsSource
Cited By21
#1Lassina Barro (TMU: Taipei Medical University)H-Index: 5
Last. Thierry Burnouf (TMU: Taipei Medical University)H-Index: 25
view all 9 authors...
A pathogen-free and standardized xeno-free supplement of growth media is required for the ex vivo propagation of human cells used as advanced therapeutic medicinal products and for clinical translation in regenerative medicine and cell therapies. Human platelet lysate (HPL) made from therapeutic-grade platelet concentrate (PC) is increasingly regarded as being an efficient xeno-free alternative growth medium supplement to fetal bovine serum (FBS) for clinical-grade isolation and/or propagation o...
1 CitationsSource
#1Yuhe Jiang (PKU: Peking University)H-Index: 1
#2Ping Zhang (PKU: Peking University)H-Index: 15
Last. Yongsheng Zhou (PKU: Peking University)H-Index: 9
view all 5 authors...
Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and microstructural degeneration. The personal and societal costs of osteoporosis are increasing year by year as the ageing of population, posing challenges to public health care. Homing disorders, impaired capability of osteogenic differentiation, senescence of mesenchymal stem cells (MSCs), an imbalanced microenvironment, and disordered immunoregulation play important roles during the pathogenesis of osteoporos...
2 CitationsSource
#1Robbie R. Goodman (U of T: University of Toronto)H-Index: 1
#2Madelaine K. Jong (U of T: University of Toronto)H-Index: 1
Last. John E. Davies (U of T: University of Toronto)H-Index: 44
view all 3 authors...
Abstract To date only small animal models have been employed to assess the effect of mesenchymal stromal cell (MSC) therapy on acute pancreatitis (AP), the most common cause of hospitalization for gastrointestinal diseases worldwide. We outline the challenges inherent in the small animal models of AP. We also point to specific benefits afforded by the adoption of larger animal models. The potential for MSC therapeutics in the treatment of AP was recognized over a decade ago. With sharper focus o...
3 CitationsSource
#1Jiaxing Liu (ECUST: East China University of Science and Technology)H-Index: 1
#2Hui Wang (ECUST: East China University of Science and Technology)H-Index: 1
Last. Wen-Song Tan (ECUST: East China University of Science and Technology)H-Index: 24
view all 6 authors...
Human umbilical cord-derived mesenchymal stem cells (hUMSCs) hold strong self-renewal capacity and low immunogenicity, which have attracted attention as potential candidates for bone repair and regeneration. However, insufficient osteogenic differentiation markedly hinders the clinical applications of hUMSCs. In the present study, the effect of β-mercaptoethanol (BME), a small molecule antioxidant which has been identified to regulate cell proliferation and differentiation, on osteogenic differe...
1 CitationsSource
#1Bogna Badyra (Jagiellonian University Medical College)H-Index: 5
#2Maciej Sułkowski (Jagiellonian University Medical College)H-Index: 6
Last. Marcin Majka (Jagiellonian University Medical College)H-Index: 40
view all 4 authors...
Neurological disorders are a massive challenge for modern medicine. Apart from the fact that this group of diseases is the second leading cause of death worldwide, the majority of patients have no access to any possible effective and standardized treatment after being diagnosed, leaving them and their families helpless. This is the reason why such great emphasis is being placed on the development of new, more effective methods to treat neurological patients. Regenerative medicine opens new thera...
4 CitationsSource
#1Kendrick To (University of Cambridge)H-Index: 4
#2Karl Romain (University of Cambridge)H-Index: 2
Last. Wasim S. Khan (University of Cambridge)H-Index: 35
view all 6 authors...
Damage to joints through injury or disease can result in cartilage loss, which if left untreated can lead to inflammation and ultimately osteoarthritis. There is currently no cure for osteoarthritis and management focusses on symptom control. End-stage osteoarthritis can be debilitating and ultimately requires joint replacement in order to maintain function. Therefore, there is growing interest in innovative therapies for cartilage repair. In this systematic literature review, we sought to explo...
3 CitationsSource
#1Jinfang Gao (Shanxi Medical University)H-Index: 2
#2Gailian ZhangH-Index: 1
view all 9 authors...
BACKGROUND: Rheumatoid arthritis (RA) is characterized by joint inflammation and damage to the cartilage and bone in collagen-induced arthritis (CIA). Mesenchymal stem cells (MSCs) can improve articular symptoms and reduce bone erosion in CIA rats; however, the underlying mechanism remains unknown. This study aimed to investigate the mechanism underlying MSC-induced improvement of bone destruction in CIA. METHODS: Wistar rats were divided into a normal group, CIA control group, MTX intervention ...
3 CitationsSource
#1Johanna BolanderH-Index: 8
#2Tim HerpelinckH-Index: 1
Last. Frank LuytenH-Index: 2
view all 3 authors...
#1Priyanka Gupta (Katholieke Universiteit Leuven)H-Index: 2
#2Gabriella Nilsson Hall (Katholieke Universiteit Leuven)H-Index: 4
Last. Ioannis Papantoniou (Katholieke Universiteit Leuven)H-Index: 15
view all 5 authors...
: Xenogeneic-free media are required for translating advanced therapeutic medicinal products to the clinics. In addition, process efficiency is crucial for ensuring cost efficiency, especially when considering large-scale production of mesenchymal stem cells (MSCs). Human platelet lysate (HPL) has been increasingly adopted as an alternative for fetal bovine serum (FBS) for MSCs. However, its therapeutic and regenerative potential in vivo is largely unexplored. Herein, we compare the effects of F...
10 CitationsSource
#1Jie Sun (ECUST: East China University of Science and Technology)H-Index: 1
#2Yan Zhou (ECUST: East China University of Science and Technology)H-Index: 18
Last. Wen-Song Tan (ECUST: East China University of Science and Technology)H-Index: 24
view all 4 authors...
Background: Mesenchymal stem cells (MSCs) are promising for cell therapy and regenerative medicine. An increased need for expanding of MSCs under serum-free condition to achieve a sufficient quantity for therapeutic applications is inevitable. Transforming growth factor-β1 (TGF-β1) is widely used for expanding clinical-grade MSCs in vitro. This work focuses on the influence of TGF-β1 on proliferation in rat bone marrow-derived MSCs (BMSCs) and the underlying mechanism.Materials and Methods: BMSC...
2 CitationsSource